Literature DB >> 16606919

Multiple sclerosis frequency in Israel's diverse populations.

Milton Alter1, Esther Kahana, Nelly Zilber, Ariel Miller.   

Abstract

BACKGROUND: Israel has served for almost half a century as a site for epidemiologic studies of multiple sclerosis (MS). Its small geographic size, well-equipped, accessible, and subsidized health facilities, trained physicians, detailed census data, and a National MS Register, maintained since 1960, offer advantages for accurate determinations of MS frequency in its diverse populations.
METHOD: The authors calculated age-specific prevalence of MS in Israeli-born Jewish inhabitants, immigrant Jews from Europe/America and from North Africa/Asia, Israeli-born Christian and Moslem Arabs, Druze, and Bedouins.
RESULTS: Prevalence rate of MS per 10(5) population on June 30, 2000, for each of these groups in the order listed was 61.6, 53.7, and 27.9 for the Jewish groups and 35.3, 14.7, 10.9, and 17.3 for the non-Jewish groups. Three tiers in MS prevalence were apparent. The highest rates were in Israeli-born Jews and in Jewish immigrants from Europe/America (significantly higher in the former than the latter). Jewish immigrants from African/Asian countries and Christian Arabs had intermediate MS rates (significantly lower than in the first two groups but not significantly different from each other). Moslem Arabs, Druze, and Bedouins had the lowest rates of MS (significantly lower than in the intermediate group but not significantly different from each other).
CONCLUSION: Diverse ethnic groups living in the same geographic area may have significantly different frequencies of MS.

Entities:  

Mesh:

Year:  2006        PMID: 16606919     DOI: 10.1212/01.wnl.0000204194.47925.0d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study.

Authors:  Khalaf Kridin; Kyle Amber; Mogher Khamaisi; Doron Comaneshter; Erez Batat; Arnon D Cohen
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

2.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.

Authors:  S-M Orton; L Wald; C Confavreux; S Vukusic; J P Krohn; S V Ramagopalan; B M Herrera; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

3.  Impact of Medicare Part D on Racial and Ethnic Minorities.

Authors:  JoEllen Jarrett Jamison; Junling Wang; Satya Surbhi; Samantha Adams; David Solomon; Kenneth C Hohmeier; Sharon McDonough; James C Eoff
Journal:  Divers Equal Health Care       Date:  2016-08-23

Review 4.  Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.

Authors:  Vladimir V Bamm; Arielle M Geist; George Harauz
Journal:  Metab Brain Dis       Date:  2016-11-02       Impact factor: 3.584

5.  Frequent misdiagnosis of adult polyglucosan body disease.

Authors:  Mark A Hellmann; Or Kakhlon; Ezekiel H Landau; Menachem Sadeh; Nir Giladi; Ilana Schlesinger; Daphne Kidron; Oded Abramsky; Avinoam Reches; Zohar Argov; Jose M Rabey; Joab Chapman; Hanna Rosenmann; Aya Gal; J Moshe Gomori; Vardiella Meiner; Alexander Lossos
Journal:  J Neurol       Date:  2015-07-21       Impact factor: 4.849

6.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

Review 7.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

8.  Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway.

Authors:  Catherine Smestad; Leiv Sandvik; Trygve Holmoy; Hanne Flinstad Harbo; Elisabeth Gulawson Celius
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849

9.  Internet usage by patients with multiple sclerosis: implications to participatory medicine and personalized healthcare.

Authors:  Izabella Lejbkowicz; Tamar Paperna; Nili Stein; Sara Dishon; Ariel Miller
Journal:  Mult Scler Int       Date:  2010-06-30

10.  Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.

Authors:  Pouya Khankhanian; Takuya Matsushita; Lohith Madireddy; Antoine Lizée; Lennox Din; Jayaji M Moré; Pierre-Antoine Gourraud; Stephen L Hauser; Sergio E Baranzini; Jorge R Oksenberg
Journal:  BMC Med Genet       Date:  2015-07-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.